Voya Investment Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$85.7 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $167,572 - $313,841	16,774 New	16,774 $310,000
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $11,712 - $20,432	-1,043 Reduced 9.43%	10,021 $138,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $126,560 - $168,400	-9,466 Reduced 46.11%	11,064 $180,000
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $20,905 - $28,591	1,464 Added 7.68%	20,530 $334,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $3,377 - $5,322	260 Added 1.38%	19,066 $283,000
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $13,666 - $21,658	884 Added 4.93%	18,806 $376,000
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $61,430 - $119,969	3,178 Added 21.55%	17,922 $414,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $84,921 - $147,328	3,469 Added 30.77%	14,744 $364,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $2.32 Million - $3.17 Million	-59,319 Reduced 84.03%	11,275 $467,000
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $741,082 - $1.46 Million	-15,869 Reduced 18.35%	70,594 $3.38 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $408,847 - $1 Million	-8,456 Reduced 8.91%	86,463 $5.44 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $2.46 Million - $5.33 Million	-42,957 Reduced 31.16%	94,919 $11.8 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $426,617 - $584,863	7,269 Added 5.57%	137,876 $9.15 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $358,286 - $555,972	4,607 Added 3.66%	130,607 $10.4 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $2.05 Million - $2.69 Million	22,304 Added 21.51%	126,000 $14.1 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $128,942 - $190,069	1,503 Added 1.47%	103,696 $10.5 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $8.29 Million - $12 Million	93,732 Added 1107.81%	102,193 $12.9 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $118,680 - $169,455	1,978 Added 30.51%	8,461 $710,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $512,965 - $654,342	-9,730 Reduced 60.01%	6,483 $399,000
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $463,446 - $579,387	7,963 Added 96.52%	16,213 $947,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $470,332 - $979,687	8,250	8,250 $479,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account